Medical Microbiology and Immunology

  Previous Article | Back to Volume | Next Article
  Abstract | References | Citation | Download | Preview | Statistics
Sample volume 1
Title Characterization and intracellular localization of putative Chlamydia pneumoniae effector proteins
Author Florian Sattelmacher, Raimond Lugert, Nicole Muller, Uwe Gross
Abstract We here describe four proteins of Chlamydia pneumoniae, which might play a role in host-pathogen interaction. The hypothetical bacterial proteins CPn0708 and CPn0712 were detected in Chlamydia pneumoniae-infected host cells by indirect immunofluorescence tests with polyclonal antisera raised against the respective proteins. While CPn0708 was localized within the inclusion body, CPn0712 was identified in the inclusion membrane and in the surrounding host cell cytosol. CPn0712 colocalizes with actin, indicating its possible interaction with components of the cytoskeleton. Investigations on CPn0809 and CPn1020, two Chlamydia pneumoniae proteins previously described to be secreted into the host cell cytosol, revealed colocalization with calnexin, a marker for the ER. Neither CPn0712, CPn0809 nor CPn1020 were able to inhibit host cell apoptosis. Furthermore, transient expression of CPn0712, CPn0809 and CPn1020 by the host cell itself had no effect on subsequent infection with Chlamydia pneumoniae. However, microarray analysis of CPn0712-expressing host cells revealed six host cell genes which were regulated as in host cells infected with Chlamydia pneumoniae, indicating the principal usefulness of heterologous expression to study the effect of Chlamydia pneumoniae proteins on host cell modulation.
Citation
References
1. Abdelrahman YM, Belland RJ (2005) The chlamydial development cycle. FEMS Microbiol Rev 29:949–959
2. Alzhanov D, Barnes J, Hruby DE, Rockey DD (2004) Chlamydial
development is blocked in host cells transfected with Chlamydia
caviae incA. BMC Microbiol 4:24
3. Bailey L, Gylfe A, Sundin C, Muschiol S, Elofsson M, Nordstrom
P, Henriques-Normark B, Lugert R, Waldenstrom A, Wolf-Watz H
(2007) Small molecule inhibitors of type III secretion in Yersinia
block the Chlamydia infection cycle. FEBS Lett 581:587–595
4. Bannantine JP, GriYths RS, Viratyosin W, Brown WJ, Rockey
DD (2000) A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane. Cell Microbiol
1:35–47
5. Buhl T, Thim L, Kofod H, Orskov C, Harling H, Holst JJ (1988)
Naturally occuring products of proglucagon 111-160 in the porcine and human small intestine. J Biol Chem 263:8621–8624
6. Carabeo RA, Mead DJ, Hackstadt T (2003) Golgi-dependent
transport of cholesterol to the Chlamydia trachomatis inclusion.
Proc Natl Acad Sci USA 100:6771–6776
7. Clifton DR, Fields KA, Grieshaber SS, Dooley CA, Fischer ER,
Mead DJ, Carabeo RA, Hackstadt T (2004) A chlamydia type III
translocated protein is tyrosine-phosphorylated at the site of entry
and associated with recruitment of actin. Proc Natl Acad Sci USA
101:10166–10171
8. Coombes BK, Mahony JB (2001) cDNA array analysis of altered
gene expression in human endothelial cells in response to Chlamydia pneumoniae infection. Infect Immun 69:1420–1427
9. Creasey EA, Delahay RM, Bishop AA, Shaw RK, Kenny B, Knutton S, Frankel G (2003) CesT is a bivalent enteropathogenic Escherichia coli chaperone required for translocation of both Tir and
Map. Mol Microbiol 47:209–221
10. Dong F, Pirbhai M, Xiao Y, Zhong Y, Wu Y, Zhong G (2005)
Degradation of the proapoptotic proteins Bik, Puma, and Bim with
Bcl-2 domain 3 homology in  Chlamydia trachomatis-infected
cells. Infect Immun 73:1861–1864
11. Dong F, Flores R, Chen D, Luo J, Zhong Y, Wu Z, Zhong G (2006)
Localization of the hypothetical protein Cpn0797 in the cytoplasm
of  Chlamydia pneumoniae-infected host cells. Infect Immun
74:6479–6486
12. Edqvist PJ, Broms JE, Betts HJ, Forsberg A, Pallen MJ, Francis
MS (2006) Tetratricopeptide repeats in the type III secretion chaperone, LcrH: their role in substrate binding and secretion. Mol
Microbiol 59:31–44
13. Fan T, Lu H, Hu H, Shi L, McClarty GA, Nance DM (1998) Inhibition of apoptosis in Chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med
187:487–496
14. Fawaz FS, van Ooij C, Homola E, Mutka SC, Engel JN (1997)
Infection with  Chlamydia trachomatis alters the tyrosine phosphorylation and/or localisation of several host cell proteins including cortactin. Infect Immun 65:5301–5308
15. Fischer SF, Vier J, Kirschnek S, Klos A, Hess S, Ying S, Hacker
G (2004) Chlamydia inhibit host cell apoptosis by degradation of
proapoptotic BH3-only proteins. J Exp Med 200:905–916
16. Fields KA, Hackstadt T (2000) Evidence for secretion of Chlamydia trachomatis CopN by a type III secretion mechanism. Mol
Microbiol 38:1048–1060
17. Fields KA, Mead DJ, Dooley CA, Hackstadt T (2003) Chlamydia
trachomatis type III secretion: evidence for a functional apparatus
during early-cycle development. Mol Microbiol 48:671–683
18. Flores R, Luo J, Chen D, Sturgeon G, Shivshankar P, Zhong Y,
Zhong G (2007) Characterization of the hypothetical proteinCpn1027, a newly identiWed inclusion membrane protein unique to
Chlamydia pneumoniae. Microbiology 153:777–786
19. Hackstadt T, Scidmore MA, Rockey DD (1995) Lipid metabolism
in Chlamydia trachomatis-infected cells: direct traYcing of Golgiderived sphingolipids to the chlamydial inclusion. Proc Natl Acad
Sci USA 92:4877–4881
20. Hackstadt T, Rockey DD, Heinzen RA, Scidmore MA (1996)
Chlamydia trachomatis interrupts an exocytic pathway to acquire
endogenously synthesized sphingomyelin in transit from the Golgi
apparatus to the plasma membrane. EMBO J 15:964–977
21. Herrmann M, Schuhmacher A, Mühldorfer I, Melchers K, Prothmann C, Dammeier S (2006) IdentiWcation and characterization of
secreted eVector proteins of Chlamydophila pneumoniae TW183.
Res Microbiol 157:513–524
22. Johnson DL, Mahony JB (2007)  Chlamydophila pneumoniae
PknD exhibits dual amino acid speciWty and phosphorylates
Cpn0712, a putative type III secretion YscD homolog. J Bacteriol
189:7549–7555
23. Janke C, Rogowski K, Wloga D, Regnard C, Kajava AV, Strub
JM, Temurak N, van Dijk J, Boucher D, van Dorsselaer A, Suryavanshi S, Gaertig J, Edde B (2005) Tubulin polyglutamylase enzymes are members of the TTL domain protein family. Science
308:1758–1762
24. Lad SP, Fukuda EY, Li J, de la Masa LM, Li E (2005) Up-regulation of JAK/STAT1 signal pathway during Chlamydia trachomatis infection. J Immunol 174:7186–7193
25. Lugert R, Kuhns M, Polch T, Gross U (2004) Expression and
localization of type III secretion-related proteins of  Chlamydia
pneumoniae. Med Microbiol Immunol 193:163–171
26. Luo J, Jia T, Flores R, Chen D, Zhong G (2007) Hypothetical protein Cpn0308 is localized in the Chlamydia pneumoniae inclusion
membrane. Infect Immun 75:497–503
27. Mannonen L, Nikula T, Haveri A, Reinikainen A, Vuola JM, Lahesmaa R, Puolakkainen M (2007) Up-regulation of host cell genes
during interferon-gamma-induced persistent Chlamydia pneumoniae infection in HL cells. J Infect Dis 195:212–219
28. Miyairi I, Byrne GI (2006) Chlamydia and programmed cell death.
Curr Opin Microbiol 9:102–108
29. Pestova TV, Kolupaeva VG, Lomakin IB, Pilipenko EV, Shatsk IN,
Agol VI, Hellen CU (2001) Molecular mechanisms of translation
initiation in eukaryotes. Proc Natl Acad Sci USA 98:7029–7036
30. Slepenkin A, de la Maza LM, Peterson EM (2005) Interaction between components of the type III secretion system of Chlamydiaceae. J Bacteriol 187:473–479
31. Stephens RS, Kalman S, Lammel C, Fan J, Marathe R, Aravind L,
Mitchell W, Olinger L, Tatusov RL, Zhao Q, Koonin EV, Davis
RW (1998) Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 23:754–759
32. Su H, McClarty G, Dong F, Hatch GM, Pan ZK, Zhong G (2004)
Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J Biol
Chem 279:9409–9416
33. Subtil A, Blocker A, Dautry-Varsat A (2000) Type III secretion
system in Chlamydia species: identiWed members and candidates.
Microbes Infect 2:367–369
34. Subtil A, Parsot C, Dautry-Varsat A (2001) Secretion of predicted
Inc proteins of Chlamydia. pneumoniae by a heterologous type III
machinery. Mol Microbiol 39:792–800
35. Subtil A, Delevoye C, Balana ME, Tastevin L, Perrinet S, DautryVarsat A (2005) A direct screen for chlamydial proteins secreted
by a type III mechanism identiWes a translocated protein and
numerous other candidates. Mol Microbiol 56:1636–1647
36. Suchland RJ, Rockey DD, Bannantine JP, Stamm WE (2000) Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane.
Infect Immun 68:360–367
37. Vandahl BB, Stensballe A, RoepstorV  P,  Christiansen  G,  Birkelund S (2005) Secretion of Cpn0796 from Chlamydia pneumoniae
into the host cell cytoplasm by an autotransporter mechanism. Cell
Microbiol 7:825–836
38. Virok D, Loboda A, Kari L, Nebozhyn M, Chang C, Nichols C,
Endresz V, Gonczol E, Berensci K, Showe MK, Showe LC (2003)
Infection of U937 monocytic cells with Chlamydia pneumoniae
induces extensive changes in host cell gene expression. J Infect
Dis 188:1310–1321
39. Wacher C, Muller M, Hofer MJ, Getts DR, Zabaras R, Ousman
SS, Terenzi F, Sen GC, King NJ, Campbell IL (2007) Coordinated
regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses. J Virol 81:860–
871
40. Woestyn S, Allaoui A, Wattiau P, Cornelis GR (1994) YscN, the
putative energizer of the Yersinia Yop secretion machinery. J Bacteriol 6:1561–1569
41. Ying S, SeiVert BM, Hacker G, Fischer SF (2005) Broad degradation of proapoptotic proteins with the conserved Bcl-2 homology
domain 3 during infection with Chlamydia trachomatis. Infect Immun 73:1399–1403
42. Zhong G, Fan T, Liu L (1999) Chlamydia inhibits interferon -
inducible major histocompatibility complex class II expression by
degradation of upstream stimulatory factor 1. J Exp Med
189:1931–1938
43. Zhong G, Liu L, Fan T, Fan P, Ji H (2000) Degradation of transcription factor RFX5 during the inhibition of both constitutive
and interferon -inducible major histocompatibility complex class
I expression in Chlamydia-infected cells. J Exp Med 191:1525–
1534
44. Zhong G, Fan P, Ji H, Dong F, Huang Y (2001) IdentiWcation of a
chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 16:935–942
Keywords Chlamydia pneumoniae - Type-III-secretion - Effector proteins
Download Full PDF Download
  Previous Article | Back to Volume | Next Article
Share
Search in articles
Statistics
Journal Published articles
MMI 51
Journal Hits
MMI 126917
Journal Downloads
MMI 585
Total users online -